- Product Details
Keywords
- Xelevia
- Janumet
- Sitagliptan
Quick Details
- ProName: Januvia
- CasNo: 486460-32-6
- Molecular Formula: CHFNO
- Appearance: Solid white
- Application: Oral
- DeliveryTime: Express delivery
- PackAge: Descrete packaging with aluminum foil
- Port: Borispol
- ProductionCapacity: Metric Ton/Month
- Purity: >99%
- Storage: Store at room temperature
- Transportation: Air
- LimitNum: 0 Metric Ton
Superiority
Synonym:Januvia; Xelevia; Sitagliptan; Janumet
Application:A DPP-4 inhibitor
CAS Number:486460-32-6
Molecular Weight:407.31
Molecular Formula:C16H15F6N5OSitagliptin is a new oral hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. This enzyme-inhibiting drug is to be used either alone or in combination with metformin or a thiazolidinedione for control of type 2 diabetes mellitus. The drug works to competitively inhibit a protein/enzyme, dipeptidyl peptidase 4 (DPP-4), that results in an increased amount of active incretins (GLP-1 and GIP), reduced amount of release of glucagon (diminishes its release) and increased release of insulin.